Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,229 | 77 | 76.3% |
| Consulting Fee | $325.00 | 1 | 20.2% |
| Education | $56.60 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $598.91 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $328.86 | 21 | $0 (2024) |
| GENZYME CORPORATION | $184.30 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $142.76 | 8 | $0 (2024) |
| PFIZER INC. | $46.77 | 2 | $0 (2020) |
| Genentech USA, Inc. | $43.84 | 3 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $39.16 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.81 | 3 | $0 (2022) |
| kaleo, Inc. | $38.45 | 2 | $0 (2021) |
| Amgen Inc. | $34.75 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.98 | 15 | GENZYME CORPORATION ($145.07) |
| 2023 | $203.04 | 12 | AstraZeneca Pharmaceuticals LP ($103.61) |
| 2022 | $150.70 | 10 | AstraZeneca Pharmaceuticals LP ($59.58) |
| 2021 | $209.27 | 13 | Regeneron Healthcare Solutions, Inc. ($33.89) |
| 2020 | $50.73 | 2 | PFIZER INC. ($34.60) |
| 2019 | $76.28 | 5 | AstraZeneca Pharmaceuticals LP ($38.26) |
| 2018 | $170.59 | 14 | GlaxoSmithKline, LLC. ($112.00) |
| 2017 | $428.95 | 9 | GlaxoSmithKline, LLC. ($389.10) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Immunology | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.58 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/22/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.56 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Immunology | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Respiratory | ||||||
| 12/08/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Immunology | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Respiratory | ||||||
| 10/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 09/27/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Respiratory | ||||||
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Respiratory | ||||||
| 07/11/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Immunology | ||||||
| 06/13/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 177 | $20,145 | $9,328 |
| 2022 | 5 | 159 | 986 | $48,171 | $20,187 |
| 2021 | 6 | 200 | 1,300 | $57,157 | $24,369 |
| 2020 | 4 | 107 | 811 | $36,028 | $13,313 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 49 | $8,020 | $4,472 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 56 | $7,240 | $3,501 | 48.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 31 | 72 | $4,885 | $1,354 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 125 | $21,005 | $11,415 | 54.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 54 | $6,920 | $3,489 | 50.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 13 | 695 | $10,796 | $2,108 | 19.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 48 | 101 | $6,850 | $1,977 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,600 | $1,198 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 92 | $15,560 | $9,073 | 58.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 105 | $13,310 | $7,116 | 53.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 18 | 971 | $15,212 | $2,982 | 19.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $4,760 | $2,446 | 51.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 47 | 93 | $6,295 | $2,062 | 32.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 18 | 19 | $2,020 | $690.86 | 34.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 160 | $20,180 | $8,784 | 43.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 12 | 586 | $9,268 | $1,952 | 21.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 22 | $3,715 | $1,639 | 44.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 28 | 43 | $2,865 | $938.58 | 32.8% |
About Dr. Ashraf Uzzaman, M.D
Dr. Ashraf Uzzaman, M.D is a Allergy & Immunology healthcare provider based in Saline, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568624773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashraf Uzzaman, M.D has received a total of $1,611 in payments from pharmaceutical and medical device companies, with $320.98 received in 2024. These payments were reported across 80 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,229).
As a Medicare-enrolled provider, Uzzaman has provided services to 547 Medicare beneficiaries, totaling 3,274 services with total Medicare billing of $67,197. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine, Pediatrics
- Location Saline, MI
- Active Since 06/29/2008
- Last Updated 03/07/2016
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568624773
Products in Payments
- BREO (Drug) $397.14
- DUPIXENT (Biological) $327.06
- TEZSPIRE (Biological) $231.11
- NUCALA (Biological) $153.19
- FASENRA (Drug) $53.03
- Xolair (Biological) $43.84
- SPIRIVA RESPIMAT (Drug) $38.81
- AUVI-Q (Drug) $38.45
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $34.60
- TRELEGY ELLIPTA (Drug) $33.44
- ALVESCO (Drug) $29.68
- SYMBICORT (Drug) $29.20
- TUDORZA PRESSAIR (Drug) $28.82
- Xhance (Drug) $21.93
- SYMJEPI (Drug) $20.00
- AIRSUPRA (Drug) $14.82
- AirDuo Digihaler (Drug) $14.71
- CUTAQUIG (Biological) $13.18
- EUCRISA (Drug) $12.17
- NIOX VERO DEVICE (Device) $10.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.